IL6 and adenoma: By examining tissue PD-L1 protein expression, serum levels of inflammatory cytokines (IL-6, IFN-γ), and fecal gut microbiota composition across various stages of CRA, including normal, NAA, and AA, our research aimed to identify biomarkers indicative of significant changes during adenoma progression.